212 related articles for article (PubMed ID: 23588592)
1. Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.
Park SH; Riley P; Frisch SM
Apoptosis; 2013 Aug; 18(8):949-62. PubMed ID: 23588592
[TBL] [Abstract][Full Text] [Related]
2. DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity.
Huan Y; Wu D; Zhou D; Sun B; Li G
Oncol Rep; 2015 Aug; 34(2):843-9. PubMed ID: 26035299
[TBL] [Abstract][Full Text] [Related]
3. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
4. PLK1 Is transcriptionally activated by NF-κB during cell detachment and enhances anoikis resistance through inhibiting β-catenin degradation in esophageal squamous cell carcinoma.
Lin DC; Zhang Y; Pan QJ; Yang H; Shi ZZ; Xie ZH; Wang BS; Hao JJ; Zhang TT; Xu X; Zhan QM; Wang MR
Clin Cancer Res; 2011 Jul; 17(13):4285-95. PubMed ID: 21610149
[TBL] [Abstract][Full Text] [Related]
5. The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling.
Wei W; Liu W; Cassol CA; Zheng W; Asa SL; Ezzat S
Mol Cell Biol; 2012 Nov; 32(22):4662-73. PubMed ID: 22988296
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.
Kanzaki H; Mukhopadhya NK; Cui X; Ramanujan VK; Murali R
Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):1-11. PubMed ID: 26871511
[TBL] [Abstract][Full Text] [Related]
7. Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation.
Kong S; Dong H; Song J; Thiruppathi M; Prabhakar BS; Qiu Q; Lin Z; Chini E; Zhang B; Fang D
J Immunol; 2015 Oct; 195(8):3685-93. PubMed ID: 26378077
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
9. Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.
Webb LV; Barbarulo A; Huysentruyt J; Vanden Berghe T; Takahashi N; Ley S; Vandenabeele P; Seddon B
Immunity; 2019 Feb; 50(2):348-361.e4. PubMed ID: 30737145
[TBL] [Abstract][Full Text] [Related]
10. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
Howe EN; Cochrane DR; Cittelly DM; Richer JK
PLoS One; 2012; 7(11):e49987. PubMed ID: 23185507
[TBL] [Abstract][Full Text] [Related]
11. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
12. The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis.
Fusella F; Seclì L; Busso E; Krepelova A; Moiso E; Rocca S; Conti L; Annaratone L; Rubinetto C; Mello-Grand M; Singh V; Chiorino G; Silengo L; Altruda F; Turco E; Morotti A; Oliviero S; Castellano I; Cavallo F; Provero P; Tarone G; Brancaccio M
Nat Commun; 2017 Nov; 8(1):1636. PubMed ID: 29158506
[TBL] [Abstract][Full Text] [Related]
13. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
14. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
15. Fas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinoma.
Liu AQ; Xie Z; Chen XN; Feng J; Chen JW; Qin FJ; Ge LY
Oncotarget; 2017 Jan; 8(5):7999-8009. PubMed ID: 28030825
[TBL] [Abstract][Full Text] [Related]
16. Dimer of arfaptin 2 regulates NF-κB signaling by interacting with IKKβ/NEMO and inhibiting IKKβ kinase activity.
You DJ; Park CR; Furlong M; Koo O; Lee C; Ahn C; Seong JY; Hwang JI
Cell Signal; 2015 Nov; 27(11):2173-81. PubMed ID: 26296658
[TBL] [Abstract][Full Text] [Related]
17. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
18. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines.
Haller D; Russo MP; Sartor RB; Jobin C
J Biol Chem; 2002 Oct; 277(41):38168-78. PubMed ID: 12140289
[TBL] [Abstract][Full Text] [Related]
19. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
Grotterød I; Maelandsmo GM; Boye K
BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
